Modeling of waning immunity after SARS-CoV-2 vaccination and influencing factors
Research output: Contribution to journal › Journal article › Research › peer-review
Documents
- Fulltext
Final published version, 27.5 MB, PDF document
SARS-CoV-2 vaccines are crucial in controlling COVID-19, but knowledge of which factors determine waning immunity is limited. We examined antibody levels and T-cell gamma-interferon release after two doses of BNT162b2 vaccine or a combination of ChAdOx1-nCoV19 and BNT162b2 vaccines for up to 230 days after the first dose. Generalized mixed models with and without natural cubic splines were used to determine immunity over time. Antibody responses were influenced by natural infection, sex, and age. IgA only became significant in naturally infected. A one-year IgG projection suggested an initial two-phase response in those given the second dose delayed (ChAdOx1/BNT162b2) followed by a more rapid decrease of antibody levels. T-cell responses correlated significantly with IgG antibody responses. Our results indicate that IgG levels will drop at different rates depending on prior infection, age, sex, T-cell response, and the interval between vaccine injections. Only natural infection mounted a significant and lasting IgA response.
Original language | English |
---|---|
Article number | 1614 |
Journal | Nature Communications |
Volume | 13 |
Issue number | 1 |
Number of pages | 11 |
ISSN | 2041-1723 |
DOIs | |
Publication status | Published - 2022 |
Bibliographical note
© 2022. The Author(s).
- Antibodies, Viral, BNT162 Vaccine, COVID-19/prevention & control, COVID-19 Vaccines, Humans, SARS-CoV-2, Vaccination, Vaccines, Inactivated, Viral Vaccines
Research areas
Number of downloads are based on statistics from Google Scholar and www.ku.dk
ID: 303110437